# Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion

> **NCT03063892** · PHASE4 · RECRUITING · sponsor: **Gregory M Georgiadis MD** · enrollment: 200 (estimated)

## Conditions studied

- Hip Fractures

## Interventions

- **DRUG:** Tranexamic Acid (TXA)
- **DRUG:** Saline solution

## Key facts

- **NCT ID:** NCT03063892
- **Lead sponsor:** Gregory M Georgiadis MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-08-30
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03063892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03063892, "Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03063892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*